New site is out yeyyyyyy

Blog Cloud Videos AI DevOps Security Software Engineering Big Tech

Recently visited

No recent pages yet.

You may also like

ChatGPT Images 2.0 is a hit in India, but not a big winner elsewhere, yet
As Tim Cook steps down, Apple hit record sales — but a chip shortage looms
Y Combinator alum Skio sells for $105M cash, only raised $8M, founder says
Sources: Anthropic potential $900B+ valuation round could happen within 2 weeks
Apple was surprised by AI-driven demand for Macs
Trump nominates Fox News doctor to be the next surgeon general
US falls below Ukraine in press freedom as global autocracy takes hold
Russia cloaks launch schedule after spaceport falls in Ukraine's sights

Curated technology updates and public resources.

About

About Us
Careers
Help Center
Contact

Partner with us

Publishers
Advertisers
Contributors
Local Business

Legal

Terms of Use
Privacy Policy
Don't Sell My Info
Community Standards

© 2026 News Aggregator. All rights reserved.

Do Not Sell or Share My Personal Information

Home/Software Engineering/Ars Technica

Ars Technica·22 days ago·John Timmer

Clinical trial shows gene editing works for β-Thalassaemia, too

Software Engineeringhealth Science clinical trial CRISPR gene editing β-Thalassaemia

Improved gene editing process reactivates the fetal version of a hemoglobin gene.

Read original article

Comments